Activity ID
14917Expires
March 24, 2029Format Type
Journal-basedCME Credit
1Fee
$30CME Provider: JAMA Network Open
Description of CME Course
Importance Over 1 million pulmonary nodules are discovered each year in the US, and many of these undergo molecular imaging–guided surgery to obtain a diagnosis. Locating a small nodule and determining its malignant potential is technically challenging and is prone to human error.
Objective To demonstrate use of a machine learning (ML) algorithm with molecular imaging to analyze imaging data during lung cancer surgery to determine malignant potential of nodules.
Design, Setting, and Participants Data were retrospectively analyzed from a prospectively collected database. Between 2014 and 2021, patients at the hospital of the University of Pennsylvania with lung nodules were included in the study. Patients in the model development set were randomly allocated into training and validation sets in an 8:2 ratio. Data were analyzed from January 2014 and December 2021.
Main Outcomes and Measures Algorithmic tumor to background ratio (TBR) detection was implemented for individual images using Image Processing Toolkit. Developed nomogram and artificial intelligence (AI) image analyzer were combined as an optical biopsy algorithm and tested prospectively between 2021 and 2024.
Results A total of 322 patients with lung nodules were included in the study, of whom 279 had complete clinical data for data analysis (175 [62.7%] female). The nomograms and image segmentation technology were developed using a large database of IMI videos (1014 video sequences) and demonstrated an area under the curve of 0.865 to 0.893 for malignant nodule assessment. On multivariate logistic regression analysis, patient smoking history of greater than 5 pack-years (patient pack-years [PPY] >5), ex vivo back table TBR greater than 2.0, ex vivo bisected tumor lesions TBR greater than 2.4, and in situ (inside the chest) fluorescence were found to have statistically significant associations with malignancy on final pathology. Prospective testing in an independent set of 61 consecutive patients during IMI-guided cancer surgery demonstrated a sensitivity of 93.8%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 71%. The study algorithm determined malignant potential of the lesion in less than 2 minutes (mean [SD], 1.8 [0.17] minutes) compared with a mean (SD) of 34 (11) minutes with frozen section analysis.
Conclusion In this cohort study of patients with indeterminate lung nodules, intraoperative imaging data analyzed by AI accurately determined if a nodule was malignant. This has the potential to improve the diagnostic challenges that occur at the time of surgery
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
To identify the key insights or developments described in this article.
Keywords
Surgery, Artificial Intelligence, Surgical Oncology, Pulmonary Medicine, Lung Cancer
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/jamanetworkopen.2025.51734